RxDoctor Payments Data

Amish Patel

Interventional Pain Medicine · Marysville, OHNPI 1265464622

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.3% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Boston Scientific at 27.6% of the total. Reporting peaked in 2019 at $712 and has fallen 71.5% since, to $203 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in OH, where the typical reported total is $5,193.

$2,387in general payments, 2019–2025

Across 106 payments — averaging $22.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$659
  • Nevro Corp.$551
  • Stryker$216
  • SPR Therapeutics, Inc$201
  • Abbott$180
  • Vertos Medical, Inc.$129
  • plus $451 from 12 others

What the payments were for

  • Travel & lodging$1617%
  • Food & beverage$2,22793%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,387 in reported general payments places this provider in the 30th percentile of 67 interventional pain medicine providers in Ohio.

See all interventional pain medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$162,850
Medicare patients
385
Services billed
1,602

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen843$20,671
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen717$11,271
Gabapentin384$3,434
Morphine Sulfate126$2,851
Hydromorphone Hcl173$2,692
Pregabalin64$2,335
Morphine Sulfate ErMorphine Sulfate91$2,241
Tramadol Hcl289$1,916
Oxycodone Hcl137$1,854
Fentanyl13$1,206
Naloxone Hcl20$1,051
Celecoxib22$846
Cyclobenzaprine Hcl88$607
Methadone Hcl41$512
Tizanidine Hcl103$426

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Marysville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →